Christopher Marsh, MD, is a transplant surgeon and chief of the division and program director of the Scripps Center for Organ and Cell Transplantation of Scripps Clinic and Scripps Green Hospital. He is also a fellow of the American College of Surgeons.
Dr. Marsh has extensive expertise in the field of transplantation, specifically in liver, kidney and pancreas transplantation. His current clinical research endeavors involve conducting clinical trials to evaluate the efficacy of novel immunosuppressive drug regimens in liver, pancreas and kidney transplants.
Dr. Marsh is at the forefront of innovative approaches, such as steroid-free immunosuppression in organ transplantation. Furthermore, he actively initiates new clinical protocols to advance the field.
Dr. Marsh's genomic and proteomic studies for post-transplant monitoring with his collaborators have improved our understanding of outcomes and improved patient care. His participation in this research has led to the development of medical tests, tailored for kidney transplant patients.
These tests provide valuable insights into their health, enhancing monitoring and management. Dr. Marsh's commitment to advancing the field through collaboration highlights his determination to optimize transplant patient care.
Dr. Marsh is highly published and has held various prestigious positions throughout his career. He is also a member of several professional societies, including the American Society of Transplant Surgeons, the International Pancreas and Islet Transplant Association, and the American and International Liver Transplant Society. He has served on multiple committees and on the board for United Network for Organ Sharing.
At Scripps, he has been chief of staff of Scripps Green Hospital, and his current roles include, vice president of surgical services, Scripps Clinic and Scripps Clinic Medical Group; surgical oncology director, Scripps cancer program; medical director, Scripps Clinic and Medical Group Bio-Repository; director, Farago Transplant Research and Education Program; and chairs the philanthropy subcommittee of the Research and Innovation Committee. Dr. Marsh is also an adjunct member in the department of Molecular Medicine at Scripps Research Institute.
